Market Indices
Sector Heatmap
ADPT — Adaptive Biotechnologies Corporation Common Stock
NasdaqAdaptive Biotechnologies Corporation Common Stock
- O
- 28.89
- H
- 29.00
- L
- 27.15
- V
- 5.84M
ADPT — Latest News & Headlines
20 StoriesAdaptive Biotechnologies (ADPT) Stock Could Be 26% Above Fair Value Despite Guideline Update - Yahoo Finance
Adaptive Biotechnologies (ADPT) Stock Could Be 26% Above Fair Value Despite Guideline Update Yahoo Finance
Adaptive Biotechnologies (NASDAQ:ADPT) Stock Rated "Buy" in New Coverage at The Goldman Sachs Group - MarketBeat
Adaptive Biotechnologies (NASDAQ:ADPT) Stock Rated "Buy" in New Coverage at The Goldman Sachs Group MarketBeat
A new myeloma cure definition requires tests able to detect one myeloma cell among a million. - Stock Titan
A new myeloma cure definition requires tests able to detect one myeloma cell among a million. Stock Titan
Adaptive Biotechnologies Corp (ADPT) Stock Down 3.1% but Still O - GuruFocus
Adaptive Biotechnologies Corp (ADPT) Stock Down 3.1% but Still O GuruFocus
Adaptive Biotechnologies slips as recent rally cools despite no clear new negative catalyst - quiverquant.com
Adaptive Biotechnologies slips as recent rally cools despite no clear new negative catalyst quiverquant.com
How NCCN Guideline Changes At Adaptive Biotechnologies (ADPT) Have Changed Its Investment Story - Simply Wall Street
How NCCN Guideline Changes At Adaptive Biotechnologies (ADPT) Have Changed Its Investment Story Simply Wall Street
Adaptive Biotechnologies CPO Francis Lo sells $3.2 million in stock By Investing.com - Investing.com Nigeria
Adaptive Biotechnologies CPO Francis Lo sells $3.2 million in stock By Investing.com Investing.com Nigeria
Adaptive Biotechnologies (ADPT) Jumped, So What Is Driving Attention Now? - Yahoo Finance
Adaptive Biotechnologies (ADPT) Jumped, So What Is Driving Attention Now? Yahoo Finance
Adaptive Biotechnologies Corp (ADPT) Stock Up 6.0% but GF Value Says Overvalued -- GF Score: 68/100 - GuruFocus
Adaptive Biotechnologies Corp (ADPT) Stock Up 6.0% but GF Value Says Overvalued -- GF Score: 68/100 GuruFocus
Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Up 4.4% - Should You Buy? - MarketBeat
Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Up 4.4% - Should You Buy? MarketBeat
Options exercised over three months will supply an officer's planned sale at Adaptive Biotechnologies (ADPT). - Stock Titan
Options exercised over three months will supply an officer's planned sale at Adaptive Biotechnologies (ADPT). Stock Titan
Will NCCN Names MRD Test Change Adaptive Biotechnologies Stock Narrative - Simply Wall Street
Will NCCN Names MRD Test Change Adaptive Biotechnologies Stock Narrative Simply Wall Street
Adaptive Biotechnologies (NASDAQ:ADPT) Price Target Raised to $34.00 at BTIG Research - MarketBeat
Adaptive Biotechnologies (NASDAQ:ADPT) Price Target Raised to $34.00 at BTIG Research MarketBeat
Adaptive Biotechnologies (ADPT) Could Be 11% Overvalued Following The Guideline Update - Simply Wall Street
Adaptive Biotechnologies (ADPT) Could Be 11% Overvalued Following The Guideline Update Simply Wall Street
ADPT Initiates Coverage On Goldman Sachs -- Rating Set to Buy - GuruFocus
ADPT Initiates Coverage On Goldman Sachs -- Rating Set to Buy GuruFocus
Is Adaptive Biotechnologies (ADPT) Fully Valued After The NCCN Guideline Update? - Simply Wall Street
Is Adaptive Biotechnologies (ADPT) Fully Valued After The NCCN Guideline Update? Simply Wall Street
Bank of America Corp DE Makes New Investment in Adaptive Biotechnologies Corporation $ADPT - MarketBeat
Bank of America Corp DE Makes New Investment in Adaptive Biotechnologies Corporation $ADPT MarketBeat
ADPT Maintained by Guggenheim -- Price Target Raised to $32 - GuruFocus
ADPT Maintained by Guggenheim -- Price Target Raised to $32 GuruFocus
Adaptive Biotechnologies (NASDAQ:ADPT) Reaches New 1-Year High - Should You Buy? - MarketBeat
Adaptive Biotechnologies (NASDAQ:ADPT) Reaches New 1-Year High - Should You Buy? MarketBeat
Adaptive Biotechnologies Corp (ADPT) Shares Fall 5.3% -- GF Value Says Still Overvalued - GuruFocus
Adaptive Biotechnologies Corp (ADPT) Shares Fall 5.3% -- GF Value Says Still Overvalued GuruFocus